Health
Vaccine Update for COVID-19
The FDA's advisory committee will meet to discuss potential updates to the COVID-19 vaccine targeting the XFG subvariant. This comes as public health officials prepare for the upcoming respiratory viral season.
Coverage timeline — 2 articles
The Hill
The Food and Drug Administration's (FDA) advisory committee on vaccines this week will consider whether to change the COVID-19 vaccine to target the XFG subvariant for the upcoming 2026-2027 respiratory viral season. The Vaccines and Related Biological Products Advisory Committee (VRBPAC) for the FD
2026-05-26 20:22 UTC
MarketWatch
The Dow turns 130 years old, and despite its recent underperformance, it still remains relevant to most investors.
2026-05-26 20:30 UTC